173 related articles for article (PubMed ID: 11568897)
21. Promoter hypermethylation profile of kidney cancer.
Dulaimi E; Ibanez de Caceres I; Uzzo RG; Al-Saleem T; Greenberg RE; Polascik TJ; Babb JS; Grizzle WE; Cairns P
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3972-9. PubMed ID: 15217927
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
23. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells.
Robert MF; Morin S; Beaulieu N; Gauthier F; Chute IC; Barsalou A; MacLeod AR
Nat Genet; 2003 Jan; 33(1):61-5. PubMed ID: 12496760
[TBL] [Abstract][Full Text] [Related]
24. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors.
Paz MF; Avila S; Fraga MF; Pollan M; Capella G; Peinado MA; Sanchez-Cespedes M; Herman JG; Esteller M
Cancer Res; 2002 Aug; 62(15):4519-24. PubMed ID: 12154064
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
26. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
[TBL] [Abstract][Full Text] [Related]
27. Identification of the methylator (serrated) colorectal cancer phenotype through precursor serrated polyps.
Messick CA; Church J; Casey G; Kalady MF
Dis Colon Rectum; 2009 Sep; 52(9):1535-41. PubMed ID: 19690479
[TBL] [Abstract][Full Text] [Related]
28. The fundamental role of epigenetics in hematopoietic malignancies.
Galm O; Herman JG; Baylin SB
Blood Rev; 2006 Jan; 20(1):1-13. PubMed ID: 16426940
[TBL] [Abstract][Full Text] [Related]
29. The CpG island methylator phenotype is not associated with a personal or family history of cancer.
Ward RL; Williams R; Law M; Hawkins NJ
Cancer Res; 2004 Oct; 64(20):7618-21. PubMed ID: 15492290
[TBL] [Abstract][Full Text] [Related]
30. Genetic and epigenetic changes in the APC gene in sporadic colorectal carcinoma with synchronous adenoma.
Kim JC; Koo KH; Roh SA; Cho YK; Kim HC; Yu CS; Kim HJ; Kim JS; Cho MK
Int J Colorectal Dis; 2003 May; 18(3):203-9. PubMed ID: 12673484
[TBL] [Abstract][Full Text] [Related]
31. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
32. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1.
Ting AH; Jair KW; Suzuki H; Yen RW; Baylin SB; Schuebel KE
Nat Genet; 2004 Jun; 36(6):582-4. PubMed ID: 15156141
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy.
Frigola J; Muñoz M; Clark SJ; Moreno V; Capellà G; Peinado MA
Oncogene; 2005 Nov; 24(49):7320-6. PubMed ID: 16007128
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic changes in solid and hematopoietic tumors.
Toyota M; Issa JP
Semin Oncol; 2005 Oct; 32(5):521-30. PubMed ID: 16210093
[TBL] [Abstract][Full Text] [Related]
35. [Role of DNA methylation in colorectal cancer].
Tokarz P; Błasiak J
Postepy Biochem; 2013; 59(3):267-79. PubMed ID: 24364209
[TBL] [Abstract][Full Text] [Related]
36. Long-range epigenetic silencing associates with deregulation of Ikaros targets in colorectal cancer cells.
Javierre BM; Rodriguez-Ubreva J; Al-Shahrour F; Corominas M; Graña O; Ciudad L; Agirre X; Pisano DG; Valencia A; Roman-Gomez J; Calasanz MJ; Prosper F; Esteller M; Gonzalez-Sarmiento R; Ballestar E
Mol Cancer Res; 2011 Aug; 9(8):1139-51. PubMed ID: 21737484
[TBL] [Abstract][Full Text] [Related]
37. [DNA methylation defects in sporadic and hereditary colorectal cancer].
Xicola RM; Llor X
Gastroenterol Hepatol; 2012; 35(7):480-7. PubMed ID: 22459641
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic studies of the adenoma-carcinoma sequence.
Fearon ER
Adv Intern Med; 1994; 39():123-47. PubMed ID: 8140953
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic changes in colorectal cancer.
Kondo Y; Issa JP
Cancer Metastasis Rev; 2004; 23(1-2):29-39. PubMed ID: 15000147
[TBL] [Abstract][Full Text] [Related]
40. Pathogenesis of CpG island methylator phenotype-positive colorectal cancers: role of genetic alteration and colonic flora.
Tahara T; Arisawa T
Epigenomics; 2014 Jun; 6(3):249-51. PubMed ID: 25111477
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]